Extracellular Vesicles as Biomarkers in Liver Disease
Open Access
- 19 December 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (24) , 16217
Abstract
Extracellular vesicles (EVs) are membrane-derived vesicles released by a variety of cell types, including hepatocytes, hepatic stellate cells, and immune cells in normal and pathological conditions. Depending on their biogenesis, there is a complex repertoire of EVs that differ in size and origin. EVs can carry lipids, proteins, coding and non-coding RNAs, and mitochondrial DNA causing alterations to the recipient cells, functioning as intercellular mediators of cell–cell communication (auto-, para-, juxta-, or even endocrine). Nevertheless, many questions remain unanswered in relation to the function of EVs under physiological and pathological conditions. The development and optimization of methods for EV isolation are crucial for characterizing their biological functions, as well as their potential as a treatment option in the clinic. In this manuscript, we will comprehensively review the results from different studies that investigated the role of hepatic EVs during liver diseases, including non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, alcoholic liver disease, fibrosis, and hepatocellular carcinoma. In general, the identification of patients with early-stage liver disease leads to better therapeutic interventions and optimal management. Although more light needs to be shed on the mechanisms of EVs, their use for early diagnosis, follow-up, and prognosis has come into the focus of research as a high-potential source of ‘liquid biopsies’, since they can be found in almost all biological fluids. The use of EVs as new targets or nanovectors in drug delivery systems for liver disease therapy is also summarized.Keywords
Funding Information
- Consejería de Salud y Familias, Junta de Andalucía (RH-122-2020, RH-002-2021, DOC_00866, PFIS F120/00201)
- Talento Doctores, PID Junta Andalucía, Fondos FEDER (RH-122-2020, RH-002-2021, DOC_00866, PFIS F120/00201)
- ISCIII (RH-122-2020, RH-002-2021, DOC_00866, PFIS F120/00201)
This publication has 109 references indexed in Scilit:
- Microscopic Studies of Various Sizes of Gold Nanoparticles and Their Cellular LocalizationsISRN Nanotechnology, 2013
- Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate CancerPLOS ONE, 2013
- Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cellsImmunology, 2012
- Death Receptor 5 Signaling Promotes Hepatocyte LipoapoptosisJournal of Biological Chemistry, 2011
- A filtration-based protocol to isolate human Plasma Membrane-derived Vesicles and exosomes from blood plasmaJournal of Immunological Methods, 2011
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Membrane BuddingCell, 2010
- Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cellsHepatology, 2010
- Activation of Macrophages by P2X7-Induced Microvesicles from Myeloid Cells Is Mediated by Phospholipids and Is Partially Dependent on TLR4The Journal of Immunology, 2010
- Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentratorAmerican Journal of Physiology-Renal Physiology, 2007